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Current imaging techniques have limited ability to detect neurotransmitters released
during brain processing. It is a critical limitation because neurotransmitters have significant
control over the brain activity. In this context, recent development of single-scan dynamic
molecular imaging technique is important because it allows detection, mapping, and
measurement of dopamine released in the brain during task performance. The technique
exploits the competition between endogenously released dopamine and its receptor
ligand for occupancy of receptor sites. Dopamine released during task performance is
detected by dynamically measuring concentration of intravenously injected radiolabeled
ligand using a positron emission tomography (PET) camera. Based on the ligand
concentration, values of receptor kinetic parameters are estimated. These estimates allow
detection of dopamine released in the human brain during task performance.
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Neuroimaging methods have made significant contribution to
our understanding of the brain and behavior by localizing spa-
tial and temporal attributes of brain processing. These methods
however, have extremely limited ability to detect changes in neu-
rochemical milieu during cognitive and behavioral processing.
As a result, neurochemistry of human cognition and behavior
remains mostly uninvestigated. Since neurochemicals, particu-
larly neurotransmitters, significantly influence the brain activity,
our understanding of the human brain will remain incomplete
until changes in neurotransmission can be studied on a real time
basis (Badgaiyan, 2011a,b).
In recent years investigators have used variations of molecular
imaging methods to detect acute changes in dopamine neu-
rotransmission during task performance (Koepp et al., 1998;
Pappata et al., 2002; Alpert et al., 2003; Normandin et al., 2007;
Wack and Badgaiyan, 2011). These methods exploit the com-
petition between endogenously released neurotransmitters and
their ligands for receptor occupancy. Because of this compe-
tition increasing or decreasing levels of endogenously released
neurotransmitter alter the concentration of an injected ligand.
Therefore, the ligand concentration measured at different brain
areas indicates the level of endogenously released neurotransmit-
ter in that area. This strategy is used to detect and map dopamine
released during task performance. In dynamic molecular imag-
ing methods volunteers receive a radiolabeled ligand prior to
initiation of a task and the ligand concentration is measured
dynamically during task performance using positron emission
tomography (PET). Based on the concentration, values of recep-
tor kinetic parameters are measured with the help of algorithms
that account for binding of the ligand to dopamine receptors (spe-
cific binding) and to the substrates outside these receptors (non-
specific binding). When dopamine is released endogenously, the
specific and non-specific binding along with the values of recep-
tor kinetic parameters are altered. The algorithms estimate these
alterations to detect, map, andmeasure dopamine released during
task-performance.
Measurement of values of receptor kinetic parameters requires
collection of multiple arterial blood samples. Based on the lig-
and concentration in these samples, specific and non-specific
binding of the ligand is estimated. Because of the need for col-
lection of serial arterial blood samples, these experiments were
performed only in a limited number of laboratories until devel-
opment of the simplified reference region model (SRRM). The
SRRM (Lammertsma and Hume, 1996; Gunn et al., 1997) allows
measurement of values of receptor kinetic parameters without the
need to collect arterial blood samples. It estimates the value in
an “activated” region by comparing it to the value measured in a
brain region (reference region) that contains a negligible amount
of dopamine receptors (e.g., cerebellum). Because of paucity of
receptors, values measured in a reference region reflect the ligand
concentration outside dopamine receptors (non-specific bind-
ing). These values are used in the kinetic models such as SRRM to
estimate ligand binding potential (BP), which is a sensitive index
of ligand binding and a measure of receptors available to the lig-
and for binding. Based on the ligand binding, release of endoge-
nous dopamine is detected and mapped. Using this method
Koepp and colleagues measured BP of the ligand 11C-raclopride
at rest (control scan) and in a second scan while the same vol-
unteers played a video game (Koepp et al., 1998). By comparing
the two BP values, they detected and mapped dopamine released
during task performance (playing video game). But this method
is not considered sensitive because it requires comparison of data
acquired in two separate scan sessions, one at rest (control task)
and the other during task performance (study task). Since the
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difference in the baseline dopaminergic activity during the two
scan sessions cannot be accurately accounted for, the need for two
separate scans compromises sensitivity of detection. This method
is therefore not suitable for detection of relatively small amounts
of dopamine released during performance of a cognitive task
(Pappata et al., 2002; Badgaiyan, 2011a).
Thus, to enhance the sensitivity, it is necessary to acquire
both control and task-induced data in the same scan session.
But the data acquired using this strategy cannot be analyzed
using SRRM because it assumes maintenance of a steady phys-
iological state throughout the scan session. By including two
conditions (control and study task) in a single scan, this assump-
tion is violated. To reconcile the violation investigators used a
variety of approaches. The initial approach involved compari-
son of the ligand BP measured during task performance with a
“normalized” BP map generated using data previously acquired
in a “control” experiment (Pappata et al., 2002). This approach,
however, is not significantly different from the two-scan method
because it also requires comparison of data acquired in two sepa-
rate scan sessions. The approach implemented in our laboratory
involves modification of algorithm used in SRRM to eliminate
the assumption of steady state (Alpert et al., 2003; Badgaiyan
et al., 2003a). The modified SRRM, called the linear extension
of simplified reference region model (LE-SRRM) (Alpert et al.,
2003) accepts changes in receptor kinetic parameters during a
scan session and allows measurement of time dependent changes
in values of these parameters.
SINGLE-SCAN DYNAMIC MOLECULAR IMAGING
TECHNIQUE
In the single scan dynamic molecular imaging technique devel-
oped in our laboratory (Alpert et al., 2003; Badgaiyan et al.,
2003b) both control and test tasks are performed in the same
scan session. Additionally, to allow detection of changes associ-
ated with a component of the task, instead of rest, appropriately
designed task is used as a control. Thus, to detect dopamine
released during emotional processing, we asked volunteers to pro-
cess emotionally neutral words in the control task and emotional
words in the study task.
In this method volunteers are positioned on the bed of a
scanner in supine position and instructed to stay still during
the entire experiment. Thereafter, a single intravenous bolus of
a radiolabeled dopamine receptor ligand (either 11C-raclopride,
10–15mCi; specific activity >1.0 Ci/μMol or 18F-fallypride, 5–
8mCi, specific activity >2.5 Ci/μMol) is administered intra-
venously at high specific activity in the left anticubital vein over
a period of 60 s. The PET data acquisition begins immedi-
ately after the injection. At the same time, the control task is
administered for 15–25min. It is important to administer the
task for about 15min to allow the ligand to achieve steady state
and to stabilize the dopamine system. After the steady state is
achieved (indicated by PET counts), test task is administered for
15–25min. Behavioral data (response time, accuracy of responses
etc.) are acquired in each trial and the PET data are acquired
either continuously (in list mode) or at 30 s epochs. The ligand
concentration is measured dynamically in each voxel (including
the reference region) at each time point during the experiment.
Based on these data, kinetic models estimate values of the recep-
tor kinetic parameters dynamically. These values are compared
with those obtained in the reference region to eliminate non-
specific binding and estimate specific binding at each time point.
The difference in values of specific binding measured during con-
trol and study task performance indicates task-induced changes.
Based on these data dopamine released during performance
of a task is detected, mapped and measured in a single scan
session.
The following operational equation is used to estimate time
dependent changes in the ligand concentration:
PET(t) = R∗CR(t)+ K∗2
∫ i
0
CR(u)du − k2a
∫ i
0
PET(u)du
− γ
∫ t
0
v(u − T)e−τ(u−T)PET(u)du
where, CR is the radioligand concentration in the reference
region, PET is the concentration in an “activated” voxel with spe-
cific binding, R is the ratio of transport rates for the binding and
reference regions, k2 describes the clearance of non-specifically
bound tracer from the voxel, and k2a includes information
about dissociation from the receptor, γ represents change in
the rate of ligand displacement, t denotes the measurement
time, T is the task initiation time and ν(u-T) is the unit step
function.
Since the rate of ligand displacement (γ) from receptor sites
closely follows endogenous dopamine release, it is considered an
important parameter for detection of dopamine release (Alpert
et al., 2003). As discussed earlier, the single scan method signifi-
cantly enhances sensitivity of detection by eliminating confounds
associated with the use of two separate scans for the control and
test conditions (Alpert et al., 2003; Badgaiyan et al., 2003b).
USE OF OTHER RECEPTOR KINETIC MODELS
In another significant development SRRM was modified by Zhou
and his colleagues to allow measurement of the ligand BP and
other receptor kinetic parameters during a specified time frame
(Zhou et al., 2006). In this modification, called the extended
simplified reference tissue model (E-SRTM), values of the recep-
tor kinetic parameters are estimated separately during perfor-
mance of the control and study tasks. Based on these estimates,
dopamine released during task performance is detected and
mapped.
Use of both LE-SRRM and E-SRTM in an analysis enhances
the reliability because these models use different approaches
to detect dopamine release. In LE-SRRM dopamine release is
detected by measuring changes in the rate of ligand displacement
during task performance while in E-SRTM detection is based on
the comparison of ligand BP measured during performance of
the control and study tasks. Further, the two models use different
strategies to eliminate assumption of steady state. In LE-SRRM
it is eliminated by allowing dissociation rate of the ligand to
change in response to an altered synaptic level of neurotrans-
mitter, while E-SRTM reconciles the violation of steady state by
assuming that the data acquired during different task conditions
(control and study) are separate datasets. Since steady state is
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maintained within each condition, this assumption allows use of
SRRM in each dataset for measurement of BP and other receptor
kinetic parameters.
When both models (LE-SRRM and E-SRTM) are used in an
analysis, results are reconciled using predefined criteria. In our
studies we consider a blob (>5 contiguous voxels) “activated”
only if: (a) there is a significant change (p < 0.05) in values of
the rate of ligand displacement estimated using LE-SRRM after
task initiation; (b) the ligand BP (measured using E-SRTM) is sig-
nificantly lower (p < 0.05) during performance of the study task
than that during the control task; (c) there is a significant increase
in dissociation coefficient (k2a) measured using E-SRTM during
study task performance; and (d) maxima of blobs identified as
“activated” by LE-SRRM and E-SRTM are located within 6mm
of each other to account for Gaussian smoothing involved in
the processing. Use of these criteria results in excellent test-retest
reliability (Badgaiyan and Wack, 2011).
SELECTION OF A LIGAND
Accuracy and reliability of detection in the single scan dynamic
molecular imaging experiments depend on specificity and recep-
tor kinetic properties of the ligand. Based on the receptor affinity
of a ligand, dopamine can be detected either in the high or low
receptor density areas of the brain. Thus, the low affinity ligand
raclopride is an excellent choice for detection of dopamine neu-
rotransmission in the high receptor density areas such as striatum.
Its binding and displacement cannot be detected or measured
in the low receptor density areas outside the striatum. We used
this ligand to detect and map striatal dopamine released during
performance of a number of cognitive, emotional and behav-
ioral tasks (Badgaiyan et al., 2003b, 2006, 2007, 2008a; Badgaiyan,
2010; Badgaiyan and Wack, 2011). Study of dopamine neuro-
transmission in low receptor density areas outside the striatum
requires a high affinity ligand such as 18F-fallypride (Badgaiyan
et al., 2009) and 11C-FLB457 (Farde et al., 1997). High-affinity
ligands are not suitable for detection of dopamine in high recep-
tor density areas because of prolonged binding time (Mukherjee
et al., 2002). We used 18F-fallypride to detect dopamine released
outside the striatum during emotional processing in healthy vol-
unteers (Badgaiyan et al., 2009). In this experiment we detected
dopamine in the amygdala, medial temporal lobe and prefrontal
cortex. Thus, depending on the ligand used, dopamine release can
be detected in different brain areas.
USE OF SINGLE-SCAN DYNAMIC MOLECULAR IMAGING
TECHNIQUE
In the past few years, the single scan dynamic molecular imag-
ing technique has been used by us (Badgaiyan et al., 2003b,
2007, 2008a,b, 2009; Badgaiyan, 2010; Badgaiyan and Wack,
2011; Badgaiyan, 2011a) and others (Christian et al., 2006;
Backman et al., 2011) to reliably detect and map dopamine
released during performance of a number of cognitive, behav-
ioral, and emotional tasks in healthy volunteers (Badgaiyan et al.,
2003b, 2007, 2008a, 2009; Christian et al., 2006; Badgaiyan, 2010;
Backman et al., 2011; Badgaiyan and Wack, 2011) and psy-
chiatric patients (Badgaiyan et al., 2008b; Badgaiyan, 2011a).
Data obtained in these experiments provide novel insight into
dopaminergic control of human brain processing. For exam-
ple, in a recent study (Badgaiyan and Wack, 2011) we found
dopamine release in discrete areas of the left caudate (Figure 1)
during performance of a task of executive inhibition (Eriksen’s
flanker task), suggesting dopaminergic processing of inhibitory
functions. Even though involvement of dopamine in the process-
ing of central inhibition was suspected for several years (Casey
et al., 2000), it was never demonstrated until we used the sin-
gle scan dynamic molecular imaging technique. In this study we
also localized clusters of striatal dopaminergic neurons involved
in the processing. Further, by following cortical connections of
these clusters we were able to understand how the striatal and
frontal areas interact to provide effective inhibition. The clus-
ter where dopamine release was most significant (medial aspect
of the head of left caudate), receives input primarily from the
orbitofrontal cortex—interestingly this input is found only on the
left hemisphere (Ferry et al., 2000). Based on this input we sug-
gested that the orbitofrontal cortex initiates inhibitory response
by modulating activities of the dopaminergic system of left
caudate.
The data acquired in single scan dynamic molecular imaging
experiments can also be used to understand neurocognitive bases
of impairments in psychiatric and neurological disorders. For
example in a recent experiment (Badgaiyan et al., 2008b) we stud-
ied dysregulated dopamine neurotransmission in attention deficit
hyperactivity disorder (ADHD).We conducted this study because
it was unclear whether the dopaminergic system is hyperactive or
hypoactive in ADHD. Studied conduced in the past used indirect
measures of dopaminergic activity and found either high or low
activity (Pliszka, 2005). We used dynamic molecular imaging to
resolve the contradiction by mapping and measuring dopamine
released in these patients during processing of an inhibitory task.
In ADHD the amount of dopamine released during inhibition of
FIGURE 1 | The figure shows significant increase in the rate of ligand
(11C-raclopride) displacement in the left caudate during performance of
an executive inhibition task (Eriksen’s flanker task). As discussed in the
text, the increased rate indicates task-induced release of dopamine. The
time activity curve shows the ligand concentration in the right caudate (open
circle) and in the cerebellum (solid circle). The cerebellum was used as a
reference region. The least square fit (solid line) of the data acquired in the
left caudate was drawn using LE-SRRM (see text). The curve shows
increased rate of ligand displacement after initiation of the task (vertical
line). In the control condition volunteers were shown congruent stimuli that
did not require activation of executive inhibition. In the test condition
incongruent stimuli were presented (study task). These stimuli activated the
executive inhibition system. The ligand concentration is expressed as
kBq/cc. Figure adapted from Badgaiyan and Wack (2011).
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unwanted responses (phasic release) was significantly enhanced
(Badgaiyan et al., 2008b) but the release at rest (tonic release) was
attenuated. This finding explains why indirect evidence suggests
either high or low dopamine activity. Studies that have indirectly
measured the phasic release have found increased activity while
indirect data that are dependent on the tonic release indicated
reduced activity.
SUMMARY
The single scan dynamic molecular imaging is an evolving tech-
nique, which expands the scope of neuroimaging research by
allowing study of neurochemical change associated with cognitive
or behavioral processing. The technique, however, is at the initial
stages of development. Therefore, at this time it cannot be used
to detect temporal sequence of events or to simultaneously detect
multiple neurotransmitters. Additionally, because task sequence
cannot be altered the control task always has to precede the
test. It therefore introduces sequence bias. Currently, efforts are
underway to resolve these limitations by developing appropriate
receptor kinetic models and by modifying experimental protocol
(Badgaiyan, 2011a,b).
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